추천 제품
분석
≥99% (HPLC)
solubility
ethanol: 2 mg/mL
DMSO: soluble
H2O: insoluble
주관자
Roche
저장 온도
2-8°C
SMILES string
COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
InChI
1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)
InChI key
ZNNLBTZKUZBEKO-UHFFFAOYSA-N
유전자 정보
human ... ABCC8(6833) , KCNH2(3757) , KCNJ1(3758) , KCNJ11(3767)
rat ... Kcnj1(24521)
유사한 제품을 찾으십니까? 방문 제품 비교 안내
애플리케이션
Glybenclamide has been used:
- as a positive control oral hypoglycemic drug to study the hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice
- as a K+ATP channel antagonist in canine with induced acute hypoxia
- as an inhibitor of cystic fibrosis transmembrane conductance regulator (CFTR) channel in fetal distal lung epithelial (FDLE) cells
생화학적/생리학적 작용
Glybenclamide is a sulfonylurea class of antidiabetic drug used in the treatment of type 2 diabetes mellitus. It has benzamide moiety and stimulates pancreatic β cells to produce insulin resulting in a hypoglycemic effect. It selectively blocks ATP-sensitive K+ channels in the brain with high-affinity binding sites and elicits cardiovascular effects. It may be a potential therapeutic for thromboembolic disorders due to its in vivo antiplatelet functionality. Glybenclamide traverses to the ischemic brain and provides neuroprotection especially during the early stages of stroke.
Selectively blocks ATP-sensitive K+ channels; high affinity binding sites found in brain, pancreatic β cells, and cardiovascular system.
특징 및 장점
This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the Chloride Channels and Potassium Channels pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
유해 및 위험 성명서
예방조치 성명서
Hazard Classifications
Aquatic Chronic 4
Storage Class Code
11 - Combustible Solids
WGK
WGK 2
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
개인 보호 장비
Eyeshields, Gloves, type N95 (US)
이미 열람한 고객
Hypoglycaemic Effect of Glibenclamide: A Critical Study on the Basis of Creatinine and Lipid Peroxidation Status of Streptozotocin-induced Diabetic Rat
Indian Journal of Pharmaceutical Sciences, 79(5), 768-777 (2017)
The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia
Intensive Care Medicine, 37(4), 701-710 (2011)
Glybenclamide: an antidiabetic with in vivo antithrombotic activity
European Journal of Pharmacology, 649(1-3), 249-254 (2010)
ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats
Experimental neurology, 235(1), 282-296 (2012)
Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice
Life Sciences, 77(9), 980-990 (2005)
관련 콘텐츠
Discover Bioactive Small Molecules for ADME/Tox
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.